Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Post-Market Study of Transcatheter Perivascular Renal Denervation for the Treatment of Hypertension Using the Ablative Solutions Inc. Peregrine System™ Infusion Catheter

NCT02570113 is registered in ClinicalTrials.gov with Ablative Solutions, Inc. as lead sponsor.

NCT NCT02570113
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02570113 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Post-Market Study of Transcatheter Perivascular Renal Denervation for the Treatment of Hypertension Using the Ablative Solutions Inc. Peregrine System™ Infusion Catheter
Lead sponsor
Ablative Solutions, Inc.
Phase
Not applicable
Overall status
Completed
Start date
November 30, 2015
Completion date
July 31, 2019
Enrollment
45 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension